| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely potassium chloride 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely valproate sodium 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely lanthanum (as lanthanum carbonate) 500 milligram/1 each conventional release chewable tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Mesalamine 500 mg prolonged-release oral tablet |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely valproate sodium 500 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Mesalamine 500 mg rectal suppository |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Niacin 500 mg prolonged-release oral tablet |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Acetaminophen 500 mg and codeine phosphate 30 mg effervescent oral tablet |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
2 |
| Domiphen bromide 500 microgram and lidocaine hydrochloride 5 mg oromucosal lozenge |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
2 |
| Product containing precisely valproic acid 500 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely dactinomycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| amoxicilline 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| céfazoline 500 mg, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| céfradine 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| acyclovir 500 mg, fiole de poudre pour perfusion (médicament clinique) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| céfotaxime 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Doripenem (as doripenem monohydrate) 500 mg powder for solution for injection vial |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| aztréonam 500 mg, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Amobarbital sodium 500 mg powder for solution for injection vial |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| amoxicilline et clavulanate de potassium 500 mg/100 mg, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
2 |
| chlorhydrate de diacétylmorphine 500 mg, pour injection |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Azithromycin (as azithromycin dihydrate) 500 mg powder for solution for injection vial |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| ampicilline 500 mg, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Deferoxamine mesylate 500 mg powder for solution for injection vial |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| clarithromycine 500 mg, fiole de poudre pour perfusion (médicament clinique) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Amifostine 500 mg powder for solution for injection vial |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| ceftazidime 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| complexe hémagglutinine-toxine botulique de type A 500 unités, pour injection (médicament clinique) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 mg powder for solution for injection vial |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely thiopental sodium 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| vancomycine 500 mg, fiole de poudre pour perfusion (médicament clinique) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| floxacilline 500 mg, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
2 |
| Product containing precisely sodium fusidate 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
2 |
| Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| ganciclovir 500 mg, fiole de poudre pour perfusion (médicament clinique) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely vigabatrin 500 milligram/1 sachet powder for conventional release oral solution (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| méropenem 500 mg, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| pipéracilline 4 g/tazobactam 500 mg, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
2 |
| Ferric ammonium citrate 16 mg/mL and folic acid 500 microgram/mL oral solution |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
2 |
| Oxybutynin chloride 500 microgram/mL oral solution |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely diazepam 500 microgram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely nitrazepam 500 microgram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely folic acid 500 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Sodium fluoride 500 microgram/mL oromucosal solution |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous cream (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Tazarotene 500 microgram/g cutaneous gel |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Clobetasol propionate 500 microgram/g cutaneous foam |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Tretinoin 500 microgram/g cutaneous cream |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Clobetasol propionate 500 microgram/g cutaneous ointment |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Clobetasone butyrate 500 microgram/g cutaneous cream |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Clobetasone butyrate 500 microgram/g cutaneous ointment |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Oxymetazoline hydrochloride 500 microgram/mL nasal spray |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous cream (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous cream |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Chlorhexidine gluconate 500 microgram/mL cutaneous solution |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous ointment |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Sodium oxybate 500 mg/mL oral solution |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Silver nitrate 500 mg/mL cutaneous solution |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely levocabastine (as levocabastine hydrochloride) 500 microgram/1 milliliter conventional release eye drops (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Alclometasone dipropionate 500 microgram/g cutaneous cream |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Mineral oil 500 mg/g and white petrolatum 500 mg/g cutaneous ointment |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Mineral oil 500 mg/g and white petrolatum 500 mg/g cutaneous ointment |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
2 |
| Product containing precisely salicylic acid 500 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely alclometasone dipropionate 500 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely desoximetasone 500 microgram/1 gram conventional release cutaneous cream (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely epinastine hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Emedastine (as emedastine difumarate) 500 microgram/mL eye drops |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Procyclidine hydrochloride 500 microgram/mL oral solution |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Fluticasone propionate 500 microgram/g cutaneous cream |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
2 |
| Product containing precisely flumazenil 500 microgram/5 milliliter conventional release solution for injection ampule (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Bretylium tosylate 500 mg/10 mL solution for injection syringe |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely bumetanide 2 milligram/4 milliliter conventional release solution for injection ampule (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely choriogonadotropin alfa 250 microgram/0.5 milliliter conventional release solution for injection syringe (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely fluorouracil (as fluorouracil sodium) 500 milligram/20 milliliter conventional release solution for injection vial (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Acetaminophen 500 mg/50 mL solution for injection vial |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely aciclovir (as aciclovir sodium) 500 milligram/20 milliliter conventional release solution for infusion vial (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Cytarabine 500 mg/5 mL solution for injection vial |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Cytarabine 500 mg/25 mL solution for injection vial |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Alfentanil (as alfentanil hydrochloride) 5 mg/10 mL solution for injection ampule |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely alfentanil (as alfentanil hydrochloride) 500 microgram/1 milliliter conventional release solution for injection ampule (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely alfentanil (as alfentanil hydrochloride) 500 microgram/1 milliliter conventional release solution for injection ampule (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely alfentanil (as alfentanil hydrochloride) 1 milligram/2 milliliter conventional release solution for injection ampule (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely alprostadil 500 microgram/1 milliliter conventional release solution for infusion ampule (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely alprostadil 500 microgram/1 milliliter conventional release solution for infusion ampule (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Amikacin (as amikacin sulfate) 500 mg/2 mL solution for injection vial |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Epoetin beta 500 unit/0.3 mL solution for injection syringe |
Has presentation strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely darbepoetin alfa 500 microgram/1 milliliter conventional release solution for injection syringe (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
500 (qualifier value) |
Inferred relationship |
Some |
1 |
FHIR